School of Pharmacy, Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.
Neurochem Res. 2020 Sep;45(9):2161-2172. doi: 10.1007/s11064-020-03076-1. Epub 2020 Jun 24.
Accumulation of amyloid-β (Aβ) peptides in the brain is regarded as a major contributor to the pathogenesis and progression of Alzheimer's disease (AD). P-glycoprotein (P-gp) as a member of ABC transporter family situated in blood brain barrier (BBB) plays a role on cleaning of Aβ via its efflux transport effect in the treatment of AD. However, the expression of P-gp in pathological BBB was lower than that in normal BBB, thus impeding the clearance of Aβ. Here, we used human brain microvascular endothelial cells (HBMVECs) derived exosomes (HBMVECs-Ex) inheriting P-gp as an extracorporeal Aβ cleansing system to remove Aβ peptides from the brain by specific capture between P-gp and Aβ. The results showed that HBMVECs-Ex inheriting P-gp greatly facilitated the cerebral clearance of Aβ by effectively transporting Aβ out of brain and potently ameliorated cognitive dysfunction in AD mice. Taken together, HBMVECs-Ex provided a new strategy on the treatment of AD.
淀粉样蛋白-β(Aβ)肽在大脑中的积累被认为是阿尔茨海默病(AD)发病机制和进展的主要原因。P-糖蛋白(P-gp)作为 ABC 转运体家族的一员,位于血脑屏障(BBB)中,通过其外排转运作用在 AD 的治疗中发挥清除 Aβ的作用。然而,在病理性 BBB 中 P-gp 的表达低于正常 BBB,从而阻碍了 Aβ的清除。在这里,我们使用携带 P-gp 的人脑血管内皮细胞(HBMVEC)衍生的外泌体(HBMVECs-Ex)作为一种体外 Aβ清除系统,通过 P-gp 与 Aβ之间的特异性结合,从大脑中去除 Aβ 肽。结果表明,携带 P-gp 的 HBMVECs-Ex 通过有效将 Aβ运出大脑,极大地促进了 Aβ在大脑中的清除,并有效地改善了 AD 小鼠的认知功能障碍。总之,HBMVECs-Ex 为 AD 的治疗提供了一种新策略。